Clinical Trial Update: CAR T-cell Therapy in Patients With Renal Dysfunction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CAR T-cell therapy in patients with renal dysfunction is currently recruiting for indications including B-cell non-Hodgkin l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Non-hodgkin Lymphoma
• Multiple Myeloma

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Northside Hospital, Inc. | Conditions: Non-hodgkin Lymphoma,B Cell, Multiple Myeloma | Phase 2 | Status: RECRUITING